Lysyl oxidases in mammalian development and certain pathological conditions

Histology and Histopathology

Volumn 24, Issue 5, 2009, Pages 651-660

  Mäki, Joni M ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Aneurysm; Branching morphogenesis; Copper enzyme; LOX

Indexed keywords

MAMMALIA;

LOXL1 PROTEIN, HUMAN; OXIDOREDUCTASE; PROTEIN LYSINE 6 OXIDASE;

ANIMAL; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MAMMAL; METABOLISM; NEOPLASM; RESPIRATORY SYSTEM; REVIEW;

AMINO ACID OXIDOREDUCTASES; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; MAMMALS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN-LYSINE 6-OXIDASE; RESPIRATORY SYSTEM;

EID: 67149096234     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Akagawa H., Narita A., Yamada H., Tajima A., Krischek B., Kasuya H., Hori T., Kubota M., Saeki N., Hata A., Mizutani T. and Inoue I. (2007). Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms. Hum. Genet. 121, 377-387.
2. Akiri G., Sabo E., Dafni H., Vadasz Z., Kartvelishvily Y., Gan N., Kessler O., Cohen T., Resnick M., Neeman M. and Neufeld G. (2003). Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res. 63, 1657-1666.
3. Alcudia J.F., Martinez-Gonzalez J., Guadall A., Gonzalez-Diez M., Badimon L. and Rodriguez C. (2008). Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by proinflammatory cytokines. Front. Biosci. 13, 2721-2727.
4. Andrews E.J., White W.J. and Bullock L.P. (1975). Spontaneous aortic aneurysms in blotchy mice. Am. J. Pathol. 78, 199-210.
5. Asuncion L., Fogelgren B., Fong K.S., Fong S.F., Kim Y. and Csiszar K. (2001). A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain. Matrix Biol. 20, 487-491.
6. Borel A., Eichenberger D., Farjanel J., Kessler E., Gleyzal C., Hulmes D.J., Sommer P. and Font B. (2001). Lysyl oxidase-like protein from bovine aorta. Isolation and maturation to an active form by bone morphogenetic protein-1. J. Biol. Chem. 276, 48944-48949.
7. Brophy C.M., Tilson J.E., Braverman I.M. and Tilson M.D. (1988). Age of onset, pattern of distribution, and histology of aneurysm development in a genetically predisposed mouse model. J. Vasc. Surg. 8, 45-48.
8. Cardoso W.V. (2001). Molecular regulation of lung development. Annu. Rev. Physiol. 63, 471-494.
9. Contente S., Kenyon K., Rimoldi D. and Friedman R.M. (1990). Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249, 796-798.
10. Csiszar K. (2001). Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res. Mol. Biol. 70, 1-32.
11. Decitre M., Gleyzal C., Raccurt M., Peyrol S., Aubert-Foucher E., Csiszar K. and Sommer P. (1998). Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. Lab. Invest. 78, 143-151.
12. Erler J.T., Bennewith K.L., Nicolau M., Dornhöfer N., Kong C., Le Q.T., Chi J.T., Jeffrey S.S. and Giaccia A.J. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226.
13. Fisk D.E. and Kuhn C. (1976). Emphysema-like changes in the lungs of the blotchy mouse. Am. Rev. Respir. Dis. 113, 787-797.
14. Fogelgren B., Polgár N., Szauter K.M., Ujfaludi Z., Laczkó R., Fong K.S. and Csiszar K. (2005). Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J. Biol. Chem. 280, 24690-24697.
15. Fong S.F., Dietzsch E., Fong K.S., Hollosi P., Asuncion L., He Q., Parker M.I. and Csiszar K. (2007). Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer 46, 644-655.
16. Gebb S.A. and Jones P.L. (2003). Hypoxia and lung branching morphogenesis. Adv. Exp. Med. Biol. 543, 117-125.
17. Gilad G.M., Kagan H.M. and Gilad V.H. (2005). Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci. Lett. 376, 210-214.
18. Görögh T., Weise J.B., Holtmeier C., Rudolph P., Hedderich J., Gottschlich S., Hoffmann M., Ambrosch P., Csiszar K. (2007). Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma. J. Pathol. 212, 74-82.
19. Guarino M., Rubino B. and Ballabio G. (2007). The role of epithelialmesenchymal transition in cancer pathology. Pathology 39, 305-318.
20. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., Saito Y., Johnson R.S., Kretzler M., Cohen C.D., Eckardt K.U., Iwano M. and Haase V.H. (2007). Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-tomesenchymal transition. J. Clin. Invest.117, 3810-3820.
21. Hirai M., Ohbayashi T., Horiguchi M., Okawa K., Hagiwara A., Chien K.R., Kita T. and Nakamura T. (2007). Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J. Cell Biol. 176, 1061-1071.
22. Holtmeier C., Görögh T., Beier U., Meyer J., Hoffmann M., Gottschlich S., Heidorn K., Ambrosch P. and Maune S. (2003). Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas. Anticancer Res. 23, 2585-2591.
23. Horn N. and Tümer Z. (2002). Menkes disease and the Occipital horn syndrome. In: Connective tissue and its heritable disorders: Molecular, genetic and medical aspects. Royce P.M. and Steinmann B. (eds). Wiley-Liss Inc., New York. pp 431-523.
24. Hornstra I. K, Birge S., Starcher B., Bailey A.J., Mecham R.P. and Shapiro S.D. (2003). Lysyl oxidase is required for vascular and diaphragmatic development in mice. J. Biol. Chem. 278,14387-14393.
25. Hough C.D., Sherman-Baust C.A., Pizer E.S., Montz F.J., Im D.D., Rosenshein N.B., Cho K.R., Riggins G.J. and Morin P.J. (2000). Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 60, 6281-6287.
26. Huang Y., Dai J., Tang R., Zhao W., Zhou Z., Wang W., Ying K., Xie Y. and Mao Y. (2001). Cloning and characterization of a human lysyl oxidase-like 3 gene (hLOXL3). Matrix Biol. 20, 153-157.
27. Ito H., Akiyama H., Iguchi H., Iyama K., Miyamoto M., Ohsawa K. and Nakamura T. (2001). Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage. J. Biol. Chem. 276, 24023-24029.
28. Jeay S., Pianetti S., Kagan H.M. and Sonenshein G.E. (2003). Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol. Cell. Biol. 23, 2251-2263.
29. Jourdan-Le Saux C., Tomsche A., Ujfalusi A., Jia L. and Csiszar K. (2001). Central nervous system, uterus, heart, and leukocyte expression of the LOXL3 gene, encoding a novel lysyl oxidase-like protein. Genomics 74, 211-218.
30. Kagan H.M. (1986). Characterization and regulation of lysyl oxidase. In Biology of extracellular matrix. Mecham. R.P. (ed). Academic Press. Orlando. pp 321-389.
31. Kagan H.M. (1994). Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol. Res. Pract. 190, 910-919.
32. Kagan H.M. and Li W. (2003). Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88, 660-672.
33. Kenyon K., Modi W.S., Contente S. and Friedman R.M. (1993). A novel human cDNA with a predicted protein similar to lysyl oxidase maps to chromosome 15q24-q25. J. Biol. Chem. 268, 18435-18437.
34. Kida K. and Thurlbeck W.M. (1980). The effects of betaaminopropionitrile on the growing rat lung. Am. J. Pathol. 101, 693-710.
35. Kirschmann D.A., Seftor E.A., Fong S.F., Nieva D.R., Sullivan C.M., Edwards E.M., Sommer P., Csiszar K. and Hendrix M.J. (2002). A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62, 4478-4483.
36. Kuhlenbäumer G., Friedrichs F., Kis B., Berlit P., Maintz D., Nassenstein I., Nabavi D., Dittrich R., Stoll M. and Ringelstein B. (2007). Association between single nucleotide polymorphisms in the lysyl oxidase-like 1 gene and spontaneous cervical artery dissection. Cerebrovasc. Dis. 24, 343-348.
37. Lazarus H.M., Cruikshank W.W., Narasimhan N., Kagan H.M. and Center D.M. (1995). Induction of human monocyte motility by lysyl oxidase. Matrix Biol. 14, 727-731.
38. Lee J.E. and Kim Y. (2006). A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity. J. Biol. Chem. 281, 37282-37290.
39. Lelièvre E., Hinek A., Lupu F., Buquet C., Soncin F. and Mattot V. (2008). VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases. EMBO J. 27, 1658-1670.
40. Li D. Y, Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., Eichwald E. and Keating M.T. (1998). Elastin is an essential determinant of arterial morphogenesis. Nature 393, 276-280.
41. Li W., Liu G., Chou I.N. and Kagan H.M. (2000). Hydrogen peroxidemediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J. Cell. Biochem. 78, 550-557.
42. Li P.A., He Q., Cao T., Yong G., Szauter K.M., Fong K.S., Karlsson J., Keep M.F. and Csiszar K. (2004). Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 120, 115-122.
43. Linz R. and Lutsenko S. (2007). Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins. J. Bioenerg. Biomembr. 39, 403-407.
44. Liu X., Zhao Y., Gao J., Pawlyk B., Starcher B., Spencer J.A., Yanagisawa H., Zuo J. and Li T. (2004). Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet. 36, 178-182.
45. Liu X., Zhao Y., Pawlyk B., Damaser M. and Li T. (2006). Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am. J. Pathol. 168, 519-528.
46. Liu G., Daneshgari F., Li M., Lin D., Lee U., Li T. and Damaser M.S. (2007). Bladder and urethral function in pelvic organ prolapsed lysyl oxidase like-1 knockout mice. BJU Int. 100, 414-418.
47. Loeys B., Van Maldergem L., Mortier G., Coucke P., Gerniers S., Naeyaert J.M. and De Paepe A. (2002). Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum. Mol. Genet. 11, 2113-2118.
48. Lucero H.A. and Kagan H.M. (2006). Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell. Mol. Life. Sci. 63, 2304-2316.
49. Lucero H.A., Ravid K., Grimsby J.L., Rich C.B., Dicamillo S.J., Mäki J.M., Myllyharju J. and Kagan H.M. (2008). Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J. Biol. Chem. 283, 24103-24117.
50. Löhler J., Timpl R. and Jaenisch R. (1984). Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 38, 597-607.
51. Mäki J.M. and Kivirikko K.I. (2001). Cloning and characterization of a fourth human lysyl oxidase isoenzyme. Biochem. J. 355, 381-387.
52. Mäki J.M., Tikkanen H. and Kivirikko K.I. (2001). Cloning and characterization of a fifth human lysyl oxidase isoenzyme: the third member of the lysyl oxidase-related subfamily with four scavenger receptor cysteine-rich domains. Matrix Biol. 20, 493-496.
53. Mäki J.M., Räsänen J., Tikkanen H., Sormunen R., Mäkikallio K., Kivirikko K.I. and Soininen R. (2002). Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106, 2503-2509.
54. Mäki J.M., Sormunen R., Lippo S., Kaarteenaho-Wiik R., Soininen R and Myllyharju J. (2005). Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am. J. Pathol. 167, 927-936.
55. Min C., Kirsch K.H., Zhao Y., Jeay S., Palamakumbura A.H., Trackman P.C. and Sonenshein G.E. (2007). The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res. 67, 1105-1112.
56. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y., Tashiro K., Ross Jr J., Honjo T. and Chien K.R. (2002). Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415, 171-175.
57. Ono K., Tanaka T., Tsunoda T., Kitahara O., Kihara C., Okamoto A., Ochiai K., Takagi T. and Nakamura Y. (2000). Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 60, 5007-5011.
58. Palamakumbura A.H., Sommer P. and Trackman P.C. (2003). Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts. J. Biol. Chem. 278, 30781-30787.
59. Palamakumbura A.H., Jeay S., Guo Y., Pischon N., Sommer P., Sonenshein G.E. and Trackman P.C. (2004). The propeptide domain of lysyl oxidase induces phenotypic reversion of rastransformed cells. J. Biol. Chem. 279, 40593-40600.
60. Payne S.L., Hendrix M.J. and Kirschmann D.A. (2006). Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/ DOCK180 signaling complex. J. Cell. Biochem. 98, 827-837.
61. Payne S.L., Hendrix M.J. and Kirschmann D.A. (2007). Paradoxical roles for lysyl oxidases in cancer-a prospect. J. Cell. Biochem. 101, 1338-1354.
62. Peinado H., Del Carmen Iglesias-de la Cruz M., Olmeda D., Csiszar K., Fong K.S., Vega S., Nieto M.A., Cano A. and Portillo F. (2005). A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 24, 3446-3458.
63. Postovit L.M., Abbott D.E., Payne S.L., Wheaton W.W., Margaryan N.V., Sullivan R., Jansen M.K., Csiszar K., Hendrix M.J. and Kirschmann D.A. (2008). Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration. J. Cell. Biochem. 103, 1369-1378.
64. Pöschl E., Schlötzer-Schrehardt U., Brachvogel B., Saito K., Ninomiya Y. and Mayer U. (2004). Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131, 1619-1628.
65. Ritch R. (2008). Exfoliation syndrome: beyond glaucoma. Arch. Ophthalmol. 126, 859-861.
66. Ritch R. and Schlötzer-Schrehardt U. (2001). Exfoliation syndrome. Surv. Ophthalmol. 2001 45, 265-315.
67. Roman J. (1997). Fibronectin and fibronectin receptors in lung development. Exp. Lung Res. 23, 147-159.
68. Rost T., Pyritz V., Rathcke I.O., Gorogh T., Dunne A.A., Werner J.A. (2003). Reduction of LOX-and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res 23, 1565-1574.
69. Saito H., Papaconstantinou J., Sato H., Goldstein S. (1997). Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence. J. Biol. Chem. 272, 8157-8160.
70. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L. and Lendahl U. (2008). Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA 105, 6392-6397.
71. Smith-Mungo L.I. and Kagan H.M. (1998). Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 16, 387-398.
72. Steinmann B., Royce P.M. and Superti-Furga A. (2002). The Ehlers-Danlos syndrome. Connective tissue and its heritable disorders. In: Molecular, genetic, and medical aspects. Royce P.M. and Steinmann B. (eds). Wiley-Liss Inc. New York. pp 431-523.
73. Sun W., Park K.W., Choe J., Rhyu I.J., Kim I.H., Park S.K., Choi B., Choi S.H., Park S.H. and Kim H. (2005). Identification of novel electroconvulsive shock-induced and activity-dependent genes in the rat brain. Biochem. Biophys. Res. Commun. 327, 848-856.
74. Tarkkanen A., Reunanen A. and Kivelä T. (2008). Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol. 86, 598-602.
75. Tchaparian E.H., Uriu-Adams J.Y., Keen C.L., Mitchell A.E. and Rucker R.B. (2000). Lysyl oxidase and P-ATPase-7A expression during embryonic development in the rat. Arch. Biochem. Biophys. 379, 71-77.
76. Ten Have-Opbroek A.A. (1991). Lung development in the mouse embryo. Exp. Lung. Res. 17, 111-130.
77. Thomassin L., Werneck C.C., Broekelmann T.J., Gleyzal C., Hornstra I.K., Mecham R.P. and Sommer P. (2005). The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers. J. Biol. Chem. 280, 42848-42855.
78. Thorleifsson G., Magnusson K.P., Sulem P., Walters G.B., Gudbjartsson D.F., Stefansson H., Jonsson T., Jonasdottir A., Jonasdottir A., Stefansdottir G., Masson G., Hardarson G.A., Petursson H., Arnarsson A., Motallebipour M., Wallerman O., Wadelius C., Gulcher J.R., Thorsteinsdottir U., Kong A., Jonasson F. and Stefansson K. (2007). Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317, 1397-1400.
79. Tsuda T., Pan T.C., Evangelisti L. and Chu M.L. (2003). Prominent expression of lysyl oxidase during mouse embryonic cardiovascular development. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 270, 93-96.
80. Vadasz Z., Kessler O., Akiri G., Gengrinovitch S., Kagan H.M., Baruch Y., Izhak O.B. and Neufeld G. (2005). Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. J. Hepatol. 43, 499-507.
81. Wasowicz M., Yokoyama S., Kashima K. and Nakayama I. (1996). The connective tissue compartment in the terminal region of the developing rat lung. An ultrastructural study. Acta Anat. (Basel). 156, 268-282.
82. Weise J.B., Csiszar K., Gottschlich S., Hoffmann M., Schmidt A., Weingartz U., Adamzik I., Heiser A., Kabelitz D., Ambrosch P. and Görögh T. (2008). Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer. Int. J. Oncol. 32, 317-322.
83. Wu M., Min C., Wang X., Yu Z., Kirsch K.H., Trackman P.C. and Sonenshein G.E. (2007a). Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res. 67, 6278-6285.
84. Wu G., Guo Z., Chang X., Kim M.S., Nagpal J.K., Liu J., Mäki J.M., Kivirikko K.I., Ethier S.P., Trink B. and Sidransky D. (2007b). LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 67, 4123-4129.
85. Zhang M.C., He L., Giro M., Yong S.L., Tiller G.E. and Davidson J.M. (1999). Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J. Biol. Chem. 274, 981-986.
86. Zuber J., Tchernitsa O.I., Hinzmann B., Schmitz A.C., Grips M., Hellriegel M., Sers C., Rosenthal A. and Schafer R. (2000). A genome-wide survey of RAS transformation targets. Nat. Genet 24, 144-152.
87. Yu Q., Horak K. and Larson D.F. (2006). Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 48, 98-104.